UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No. 2)
INTERLEUKEN GENETICS, INC.
--------------------------
(Name of Issuer)
Common Stock, no par value
--------------------------
(Title of Class of Securities)
(CUSIP Number)
MSSI LLC
c/o Richard L. Fisher
299 Park Avenue
New York, NY 10017
(212) 752-5000
-----------------------
(Name, Address and Telephone Number of Person Authorized
to Receive Notices and Communications)
copy to:
John N. Turitzin
Battle Fowler LLP
75 East 55th Street
New York, NY 10022
(212) 856-7000
March 14, 2000
- --------------------------------------------------------------------------------
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to report
the acquisition which is the subject of this Schedule 13D, and is filing this
schedule because of Rule 13d-1(b)(3) or (4), check the following box / /.
Note: Six copies of this statement, including all exhibits, should be filed with
the Commission. See Rule 13d-1(a) for other parties to whom copies are to be
sent.
Page 1 of 7 Pages
929640.1 --- ---
<PAGE>
CUSIP No. SCHEDULE 13D
---------------
- --------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
MSSI LLC 13-4075839
- --------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) / /
(b) /X/
- --------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------
4 SOURCE OF FUNDS*
- --------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
ITEMS 2(d) or 2(e) / /
- --------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
New York
- --------------------------------------------------------------------------------
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH 7 SOLE VOTING POWER
1,500,000
-------------------------------------------------------------------
8 SHARED VOTING POWER
0
-------------------------------------------------------------------
9 SOLE DISPOSITIVE POWER
1,500,000
-------------------------------------------------------------------
10 SHARED DISPOSITIVE POWER
0
- --------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,500,000
- --------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES* / /
- --------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
8.38%
- --------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON*
00
- --------------------------------------------------------------------------------
* THE REMAINDER OF THIS COVER PAGE SHALL BE FILLED OUT FOR A REPORTING PERSON'S
INITIAL FILING ON THIS FORM WITH RESPECT TO THE SUBJECT CLASS OF SECURITIES, AND
FOR ANY SUBSEQUENT AMENDMENT CONTAINING INFORMATION WHICH WOULD ALTER
DISCLOSURES PROVIDED IN A PRIOR COVER PAGE.
Page 2 of 7 Pages
929640.1 --- ---
<PAGE>
THE INFORMATION REQUIRED ON THE REMAINDER OF THIS COVER PAGE SHALL NOT BE DEEMED
TO BE "FILED" FOR THE PURPOSE OF SECTION 18 OF THE SECURITIES EXCHANGE ACT OF
1934 ("ACT") OR OTHERWISE SUBJECT TO THE LIABILITIES OF THAT SECTION OF THE ACT
BUT SHALL BE SUBJECT TO ALL OTHER PROVISIONS OF THE ACT (HOWEVER, SEE THE
NOTES).
Page 3 of 7 Pages
929640.1 --- ---
<PAGE>
Amendment No. 2
to
Schedule 13D
This Amendment No. 2 to Schedule 13D amends and supplements
the original Schedule 13D, dated August 20, 1999, as amended by Amendment No.1,
dated November 10,1999, which was filed with the Securities and Exchange
Commission (the "Commission") on September 13, 1999, on behalf of MSSI LLC, with
respect to the ownership of Common Stock, no par value ("Common Stock"), of
Interleukin Genetics, Inc., a Texas corporation. Each capitalized term not
defined in this amendment has the same meaning here as in the original 13D.
I. Item 5 of the Schedule 13D "Interest in Securities of the Issuer" is
amended and restated as follows:
(a) As of the close of business on March 10, 2000, MSSI LLC
beneficially owned 1,500,000 shares of Common Stock, representing approximately
8.38% of the Company's outstanding shares of Common Stock.
(b) From March 6, 2000 through March 10, 2000, MSSI LLC sold
200,000 shares of Common Stock, in open market transactions as set forth on
Schedule I attached hereto.
Page 4 of 7 Pages
929640.1 --- ---
<PAGE>
SCHEDULE I
----------
Date Amount of Securities Sold Price Per Share
- --------------------------------------------------------------------------------
3/06/00 4400 $16.75
- --------------------------------------------------------------------------------
5000 $15.875
- --------------------------------------------------------------------------------
5000 $17.00
- --------------------------------------------------------------------------------
7000 $16.125
- --------------------------------------------------------------------------------
8000 $16.875
- --------------------------------------------------------------------------------
10,000 $15.25
- --------------------------------------------------------------------------------
10,000 $16.25
- --------------------------------------------------------------------------------
10,000 $16.375
- --------------------------------------------------------------------------------
10,800 $16.50
- --------------------------------------------------------------------------------
5000 $16.25
- --------------------------------------------------------------------------------
3/07/00 1000 $14.75
- --------------------------------------------------------------------------------
1000 $15.50
- --------------------------------------------------------------------------------
17,500 $14.00
- --------------------------------------------------------------------------------
1000 $15.9375
- --------------------------------------------------------------------------------
1000 $16.00
- --------------------------------------------------------------------------------
1000 $14.625
- --------------------------------------------------------------------------------
3000 $14.4375
- --------------------------------------------------------------------------------
3000 $14.25
- --------------------------------------------------------------------------------
5000 $14.375
- --------------------------------------------------------------------------------
9000 $14.50
- --------------------------------------------------------------------------------
3/08/00 30,000 $12.8596
- --------------------------------------------------------------------------------
3/09/00 30,500 $12.793
- --------------------------------------------------------------------------------
3/10/00 21,800 $12.8108
- --------------------------------------------------------------------------------
Total 200,000
- --------------------------------------------------------------------------------
Page 5 of 7 Pages
929640.1 --- ---
<PAGE>
SIGNATURE
After reasonable inquiry and to the best of my knowledge and
belief, I certify that the information set forth in this statement is true,
complete and correct.
MSSI LLC
By: /s/ M. Anthony Fisher
------------------------
Name: M. Anthony Fisher
Title: Managing Member
Dated: As of March 14, 2000
929640.1
1
